ICU Medical, Inc. (ICUI)
NASDAQ: ICUI · IEX Real-Time Price · USD
117.53
+2.65 (2.31%)
Jul 2, 2024, 4:00 PM EDT - Market closed

ICU Medical Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year
20232022202120202019 2018 - 1995
Cash & Equivalents
254.22208.78552.83396.1268.67
Upgrade
Short-Term Investments
0.54.2214.4214.6923.97
Upgrade
Cash & Cash Equivalents
254.72213.01567.25410.78292.64
Upgrade
Cash Growth
19.58%-62.45%38.09%40.37%-23.42%
Upgrade
Receivables
161.57221.72105.89124.09202.22
Upgrade
Inventory
709.36696.01290.24314.93337.64
Upgrade
Other Current Assets
95.62104.4666.4370.9749.7
Upgrade
Total Current Assets
1,2211,2351,030920.78882.2
Upgrade
Property, Plant & Equipment
682.82710.98508.21513.2490.55
Upgrade
Long-Term Investments
00.524.6212.970
Upgrade
Goodwill and Intangibles
2,3432,432231.75230.23242.65
Upgrade
Other Long-Term Assets
131.32136.93106.3586.5176.98
Upgrade
Total Long-Term Assets
3,1573,280850.93842.91810.19
Upgrade
Total Assets
4,3784,5161,8811,7641,692
Upgrade
Accounts Payable
150.03215.981.1371.86128.63
Upgrade
Current Debt
5129.69000
Upgrade
Other Current Liabilities
280.81248.97119.65123.62119.84
Upgrade
Total Current Liabilities
481.84494.56200.78195.49248.47
Upgrade
Long-Term Debt
1,5781,624000
Upgrade
Other Long-Term Liabilities
195.42307.4863.9365.9466.67
Upgrade
Total Long-Term Liabilities
1,7731,93163.9365.9466.67
Upgrade
Total Liabilities
2,2552,426264.71261.43315.14
Upgrade
Total Debt
1,6291,653000
Upgrade
Debt Growth
-1.49%----
Upgrade
Retained Earnings
807.85837.5911.79808.65721.78
Upgrade
Comprehensive Income
-53.08-80.98-19.27-1.52-15.4
Upgrade
Shareholders' Equity
2,1232,0901,6161,5021,377
Upgrade
Net Cash / Debt
-1,374.05-1,440.36567.25410.78292.64
Upgrade
Net Cash / Debt Growth
--38.09%40.37%-23.42%
Upgrade
Net Cash Per Share
-57.04-60.3526.0419.0313.58
Upgrade
Working Capital
739.43740.64829.03725.29633.73
Upgrade
Book Value Per Share
88.1487.5676.2171.8666.76
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).